SCHEMBL1300948

SCHEMBL1300948

CCNC(C)N[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1960602 0.77 ADH1B (0.33)
SCHEMBL1960039 0.77 CA2 (0.33)
SCHEMBL1963987 0.73
SCHEMBL2063176 0.73
SCHEMBL1964015 0.70 MMP1 (0.30)
SCHEMBL2981059 0.69
SCHEMBL1963277 0.68 TSHR (0.50)
SCHEMBL5902560 0.67
SCHEMBL3027384 0.67
SCHEMBL25179 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053114-B2 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives SUGEN, INC. (US) 2006-05-30 US claimed
EP-1575947-A1 2-OXOPYRIDIN-3-YL THIA(DI)AZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES Amgen Inc. (US) 2005-09-21 EP claimed
US-20040147561-A1 Pyrid-2-one derivatives and methods of use SYNGENTA CROP PROTECTION AG (CH) 2004-07-29 US claimed
WO-2004060890-A1 2-OXOPYRIDIN-3-YL THIA (DI) AZOLE DERIVATES FOR USE IN THE TREATMENT OF CELL PROLIFERATION AND APOPTOSIS RELATED DISEASES AMGEN INC. (US) 2004-07-22 WO claimed
WO-2024117980-A1 COMPOUNDS FOR MODULATING SRC FAMILY KINASES AND USES THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2024-06-06 WO disclosed
US-20220380317-A1 COMPOUNDS HAVING ANTIMALARIAL ACTIVITY NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2022-12-01 US disclosed
EP-3990434-A1 COMPOUNDS HAVING ANTIMALARIAL ACTIVITY Nanyang Technological University (SG) 2022-05-04 EP disclosed
WO-2020263191-A1 COMPOUNDS HAVING ANTIMALARIAL ACTIVITY NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2020-12-30 WO disclosed
EP-3354635-A1 NOVEL ANTIMICROBIAL COMPOUNDS AND USES THEREOF Agency For Science, Technology And Research (SG) 2018-08-01 EP disclosed
EP-2569273-B1 NOVEL ANTIMICROBIAL COMPOUNDS AND USES THEREOF AGENCY SCIENCE TECH & RES (SG) 2018-04-04 EP disclosed
EP-2129653-B1 NOVEL P2Y12 RECEPTOR ANTAGONISTS Rheinische Friedrich-Wilhelms-Universität Bonn (DE) 2017-05-17 EP disclosed
US-9012505-B2 Antimicrobial compounds and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-04-21 US disclosed
US-20020032204-A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives SUGEN INCORPORATED 2002-03-14 US disclosed
US-6335327-B1 Benzoheterocyclic derivatives OTSUKA PHARMACEUTICALS CO., LTD. (JP) 2002-01-01 US disclosed
WO-2001090103-A2 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS SUGEN, INC. (US) 2001-11-29 WO disclosed
WO-2001090104-A2 -(PYRROLIDIN-1-YLMETHYL)-3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AND THEIR USE AS MODULATORS OF PROTEIN KINASES PHARMACIA & UPJOHN COMPANY (US) 2001-11-29 WO disclosed
WO-2001090068-A2 MANNICH BASE PRODRUGS OF 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES AND THEIR USE A MODULATORS OF PROTEIN KINASES SUGEN, INC. (US) 2001-11-29 WO disclosed
US-6096735-A Benzoheterocyclic derivatives OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 2000-08-01 US disclosed
EP-0765314-A1 BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-04-02 EP disclosed
WO-1995034540-A1 BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-12-21 WO disclosed